Kuros Biosciences AG (KURN SW) stock market data APIs
CHF20.848
1.07(5.1%)
as of April 17, 2025
Kuros Biosciences AG Financial Data Overview
Kuros Biosciences AG engages in the commercialization and development of biologic technologies for musculoskeletal care in the United States of America, the European Union, and internationally. It operates through two segments, Medical Devices and Legacy Portfolio. The company offers MagnetOs Granules, an original advanced bone graft based on the submicron needle-shaped NeedleGrip surface technology; MagnetOs Putty, a mold uses to fill bony voids for intervertebral disc space or posterolateral spine; and Attrax, a biphasic calcium phosphate bone grafts that mimic the porous and trabecular structure of cancellous bone, as well as checkmate licensing. The company was incorporated in 2016 and is headquartered in Schlieren, Switzerland.
Prev. Close
20.848
Open
21.9176
High
22.1409
Low
20.5293
52 wk Range
6.18-32
Market Cap
797 M
Shares Outstanding
37 960 K
Revenue
75 555 K
Beta
0.59
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Kuros Biosciences AG data using free add-ons & libraries
Get Kuros Biosciences AG Fundamental Data
Kuros Biosciences AG Fundamental data includes:
- Net Revenue: 75 555 K
- EBITDA: 2 056 K
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-04-17
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Kuros Biosciences AG News
New
Kuros Biosciences to Host Key Opinion Leader Meeting in Zurich Showcasing its Commercial Stage Advanced Bone Graft MagnetOs
SCHLIEREN (ZURICH), Switzerland, Oct. 02, 2019 (GLOBE NEWSWIRE) -- Kuros Biosciences, (SWX: KURN) a full-fledged orthobiologics company with scientific, clinical, and commercial excellence in bone r...
Kuros Biosciences to Host Key Opinion Leader Meeting on Establishing the New Gold Standard in Bone Regeneration
SCHLIEREN (ZURICH), Switzerland, Sept. 13, 2018 (GLOBE NEWSWIRE) -- Kuros Biosciences, (SWX:KURN) a full-fledged orthobiologics company with scientific, clinical, and commercial excellence in bone r...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
